Segmentectomy
Segmentectomy is a medical procedure with 10 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
5
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Postoperative Pulmonary Function Assessment Based on Deep Learning Study
Segmentectomy After Induction Therapy (SAINT)
SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)
Segmentectomy for Solid-dominant Lung Cancer
Clinical Trials (10)
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Postoperative Pulmonary Function Assessment Based on Deep Learning Study
Segmentectomy After Induction Therapy (SAINT)
SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)
Segmentectomy for Solid-dominant Lung Cancer
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Contribution of 3D Printing in Anatomical Lung Segmentectomies.
Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field
Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC
Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC
All 10 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 10